Abbott (ABT) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings
Depreciation	605M
Amortization of intangibles	429M
Share-based compensation	263M
Acquired in-process research and development
Trade receivables	-116M
Inventories	-152M
Other, net	-1B
Net Cash From Operating Activities	2.03B
Acquisitions of property and equipment	-802M
Acquisitions of businesses and technologies, net of cash acquired	-73M
(Purchases of) proceeds from sales of investment securities, net	-982M
Release of (deposit of) restricted funds
Other	34M
Net Cash (Used in) Investing Activities	-1.8B
Proceeds from issuance of (repayments of) short-term debt and other	-682M
Proceeds from issuance of long-term debt	0
Payment of long-term debt	-11M
Purchases of common shares	-522M
Proceeds from stock options exercised, including income tax benefit	206M
Dividends paid	-1.15B
Net Cash (Used in) Financing Activities	-2.36B
Effect of exchange rate changes on cash and cash equivalents	-379M
Net Increase (Decrease) in Cash and Cash Equivalents	-2.5B
Cash and Cash Equivalents, Beginning of Year	5B
Cash and Cash Equivalents, End of Period	2.5B

Entities mentioned with ABT

View All Entities